action
chemokin
interact
specif
receptor
go
beyond
origin
defin
role
recruit
leukocyt
inflam
tissu
chemokin
receptor
express
peripher
element
resid
cell
central
nervou
system
cn
repres
relev
commun
system
neuroinflammatori
condit
follow
exampl
describ
review
chemokin
receptor
play
import
homeostat
properti
regul
level
specif
ligand
blood
tissu
healthi
patholog
condit
chemokin
receptor
clearli
involv
leukocyt
extravas
recruit
cn
current
studi
direct
toward
understand
interact
chemokin
receptor
matrix
metalloproteinas
process
blood
brain
barrier
breakdown
also
propos
novel
function
chemokin
receptor
demyelinationremyelin
development
process
j
leukoc
biol
key
word
demyelin
matrix
metalloproteinas
mmp
blood
brain
barrier
bbb
experiment
autoimmun
encephalomyel
eae
coronaviru
develop
author
contribut
equal
work
central
nervou
system
cn
character
rel
immunosuppress
environ
result
lack
lymphat
drainag
resid
dendrit
cell
dc
mhc
express
moreov
blood
brain
barrier
bbb
restrict
inflammatori
leukocyt
traffick
cn
howev
cn
potenti
develop
effici
innat
adapt
regulatori
immun
respons
neuroinflammatori
disord
multipl
sclerosi
ms
mainten
special
environ
disturb
loss
bbb
integr
critic
event
diseas
pathogenesi
bbb
disrupt
allow
leukocyt
travers
vessel
wall
accumul
within
perivascular
space
progress
across
glia
limitan
parenchyma
initi
destruct
inflammatori
respons
event
strictli
regul
adhes
molecul
chemokin
matrix
metalloproteinas
mmp
chemokin
system
compris
molecul
receptor
human
ortholog
mammalian
speci
chemokin
ligand
superfamili
divid
subgroup
largest
cc
chemokin
member
cxc
chemokin
member
chemokin
subgroup
member
encod
multigen
array
function
relat
signal
correspond
famili
chemokin
receptor
gproteincoupl
receptor
gpcr
act
specif
pertussi
toxinsensit
g
compon
gpcr
drug
target
biotechpharmaceut
industri
mount
substanti
effort
modul
chemokin
receptor
activ
heighten
medic
import
chemokinemedi
regul
homeostat
inflammatori
process
first
identifi
abil
mediat
leukocyt
chemoattract
vitro
chemokin
recogn
govern
wide
array
function
inflamm
immun
past
decad
chemokin
receptor
local
variou
cell
type
blood
leukocyt
particular
interest
cn
specif
chemokin
receptor
detect
microglia
astrocyt
oligodendrocyt
neuron
brain
microvasculatur
import
corollari
statement
use
immunohistochemistri
need
alway
control
appropri
studi
receptordefici
knockout
mice
avail
given
notori
lack
specif
reagent
situ
hybrid
also
need
use
confirm
find
import
defin
role
chemokin
receptor
healthi
mice
model
neural
patholog
describ
experiment
approach
use
studi
chemokin
biolog
vivo
normal
neuroinflammatori
condit
report
observ
regard
role
chemokin
receptor
ligand
homeostasi
demyelin
remyelin
connect
mmp
bbb
breakdown
particip
development
process
fig
chemokinebind
molecul
aka
nonsign
decoy
receptor
chemokin
sequestr
three
chemokin
receptorlik
duffi
antigen
receptor
chemokin
darc
chemocentryxchemokin
receptor
ccxckr
also
known
capac
bind
chemokin
without
evok
prototyp
cellular
respons
chemotaxi
activ
atyp
receptor
sequest
chemokin
regul
bioavail
therefor
critic
regul
inflamm
duffi
blood
group
antigen
describ
year
ago
later
recogn
entri
receptor
erythrocyt
malari
parasit
duffi
antigen
name
darc
shown
unusu
capabl
bind
broad
spectrum
chemokin
cc
cxc
subfamili
darc
express
endotheli
cell
accordingli
involv
transfer
chemokin
across
endothelium
result
abund
red
blood
cell
rbc
darc
seen
receptor
involv
clearanc
chemokin
blood
extrem
promiscu
receptor
bind
least
chemokin
cc
subfamili
inflammatori
chemokin
mice
lack
exhibit
exagger
cutan
inflammatori
respons
increas
suscept
develop
skin
cancer
unexpectedli
mice
also
resist
induct
experiment
autoimmun
encephalomyel
eae
result
impair
encephalitogen
respons
analys
skin
tissu
immun
site
mice
show
aggreg
suggest
dc
might
trap
site
antigen
inject
therefor
limit
antigen
present
contrast
properti
ccxckr
bind
homeostat
chemokin
human
ccxckr
predict
modul
homoeostat
lymphocyt
dc
traffick
key
migratori
event
acquir
immun
respons
direct
ccxckrbind
chemokin
reveal
function
biochem
divers
within
chemokin
receptor
famili
provid
insight
novel
mechan
chemokin
regul
past
year
studi
role
fractalkin
receptor
cn
inflamm
fractalkin
uniqu
cn
chemokin
present
neuron
membran
capabl
releas
solubl
protein
constitut
stressactiv
disintegrin
metalloproteinasefamili
proteas
activ
fractalkin
exert
function
bind
microgli
cell
although
mainli
produc
cn
fractalkin
also
distinct
peripher
pattern
express
fractalkin
found
low
level
endotheli
epitheli
cell
select
tissu
kidney
lung
prostat
heart
spleen
liver
cn
endotheli
cell
express
fractalkin
circul
monocyt
nk
cell
express
studi
determin
level
solubl
fractalkin
normal
healthi
mous
brain
found
level
solubl
fractalkin
wildtyp
mice
dramat
differ
mice
exhibit
time
solubl
fractalkin
brain
serum
compar
normal
wildtyp
mice
observ
led
us
hypothes
signal
chemokin
receptor
requir
ligand
homeostasi
continu
studi
determin
level
ligand
variou
chemokin
receptordefi
fig
understand
biolog
chemokin
receptor
focu
research
schemat
present
four
differ
area
integr
complex
observ
suggest
key
regulatori
function
chemokin
receptor
observ
suggest
signal
chemokin
receptor
play
role
clearanc
specif
ligand
import
implic
receptor
bind
one
ligand
blockad
approach
propos
explor
context
demyelin
model
preliminari
data
show
absenc
cn
associ
enhanc
tissu
repair
also
present
import
chemoattract
neutrophil
jhm
strain
mous
hepat
viru
jhmv
infect
current
studi
role
neutrophilderiv
bbb
integr
development
studi
use
examin
role
neurogenesi
cient
strain
fig
analyz
mous
line
lack
chemokin
receptor
includ
member
cc
cxc
receptor
famili
addit
doubledefici
mice
chemokin
receptordefici
line
allow
us
determin
level
constitut
ligand
inflammatori
ligand
circul
serum
tissu
healthi
condit
result
indic
defici
chemokin
receptor
associ
increas
level
correspond
ligand
mice
exhibit
approxim
three
time
circul
compar
wildtyp
mice
show
level
circul
increas
compar
wildtyp
mice
circul
level
wildtyp
mice
undetect
howev
induc
eae
found
mice
exhibit
significantli
higher
level
examin
chemokin
level
cn
tissu
express
also
reveal
ligand
significantli
higher
mice
respect
compar
wildtyp
mice
express
analysi
show
mrna
level
compar
wildtyp
mice
indic
increas
caus
accumul
mrna
reconstitut
mice
wildtyp
bone
marrow
substanti
restor
chemokin
homeostasi
support
notion
chemokin
clear
peripheri
instanc
cn
tissu
cell
express
specif
receptor
differ
observ
ligand
concentr
variou
chemokin
receptordefici
mice
analyz
clear
might
result
degre
promiscu
receptor
rel
express
level
ligand
altern
receptor
well
document
chemokin
function
suppress
chemokin
receptor
desensit
intern
upon
ligand
bind
therefor
examin
whether
ligand
present
high
concentr
could
alter
express
altern
receptor
cardin
receptor
absent
perform
assay
flow
cytometri
pbmc
resid
periton
macrophag
mice
analyz
function
avail
found
proport
cell
reduc
significantli
mice
compar
wildtyp
mice
therefor
excess
ligand
bind
downregul
receptor
involv
chemokin
receptor
homeostasi
specif
ligand
came
studi
show
rapid
use
wildtyp
macrophag
increas
amount
mice
respons
alloantigen
moreov
group
report
consum
migrat
pbmc
human
bbb
model
observ
support
import
biolog
role
signal
chemokin
receptor
scaveng
specif
ligand
fig
mmp
larg
famili
proteolyt
enzym
involv
degrad
protein
compon
extracellular
matrix
collagen
elastin
fibronectin
laminin
highli
regul
enzym
implic
varieti
physiolog
angiogenesi
bone
remodel
etc
patholog
process
particular
pathogenesi
cn
inflammatori
disord
increas
express
sever
mmp
found
serum
cerebrospin
fluid
cn
ms
patient
variou
mmp
also
increas
cn
experiment
ms
mous
model
addit
intracerebr
inject
mmp
healthi
mice
induc
bbb
breakdown
leukocyt
recruit
wherea
mmp
inhibit
block
onset
develop
eae
even
revers
diseas
among
mmp
particular
interest
increas
serum
ms
patient
especi
clinic
relaps
correl
diseas
activ
gadoliniumenhanc
brain
magnet
reson
imag
furthermor
young
mice
resist
eae
find
implic
bbb
disrupt
collabor
dr
cornelia
bergmann
steve
stohlman
evalu
role
bbb
disrupt
use
murin
model
cn
demyelin
induc
neurotrop
coronaviru
jhmv
infect
jhmv
infect
along
theiler
murin
encephalomyel
viru
tmev
repres
excel
viral
model
studi
mechan
involv
demyelin
diseas
ms
cn
infect
neurotrop
strain
mous
hepat
viru
mhv
induc
acut
inflammatori
respons
follow
chronic
cn
infect
ongo
demyelin
contrast
tmev
infect
infecti
mhv
remain
undetect
chronic
phase
jhmv
infect
although
viral
antigen
rna
present
furthermor
chemokin
mmp
express
jhmv
infect
well
character
provid
basi
studi
individu
factor
contribut
parenchym
cn
infiltr
leukocyt
known
protein
level
increas
jhmv
infect
correl
neutrophil
recruit
howev
mrna
alter
unlik
mrna
appear
upregul
neutrophil
store
within
granul
abund
inflammatori
cell
enter
cn
earli
infect
infiltr
correl
rapid
declin
bbb
integr
studi
role
neutrophil
bbb
disrupt
jhmv
infect
neutrophil
deplet
use
antibodi
neutrophil
deplet
result
reduct
leukocyt
brain
lessen
bbb
disrupt
absenc
activ
suggest
role
enzym
bbb
breakdown
howev
direct
implic
mediat
loss
bbb
integr
demonstr
address
question
mice
infect
jhmv
preliminari
data
reveal
decreas
leukocyt
infiltr
infect
mice
compar
wildtyp
control
c
savarin
cornelia
bergmann
stephan
stohlman
unpublish
result
analys
bbb
permeabl
need
perform
confirm
direct
role
bbb
disrupt
interest
character
cell
type
respons
releas
jhmv
infect
antibodi
classic
use
neutrophil
deplet
recogn
two
distinct
surfac
antigen
express
neutrophil
high
immatur
bone
marrowderiv
macrophag
high
suggest
antibodi
treatment
deplet
neutrophil
recruit
monocyt
importantli
macrophag
constitut
second
popul
present
cn
peak
neutrophil
infiltr
follow
jhmv
infect
repres
potenti
sourc
assess
specif
contribut
releas
neutrophil
andor
macrophag
bbb
disrupt
jhmv
pathogenesi
studi
mice
use
mice
chemokin
receptor
bind
two
major
neutrophil
chemoattract
jhmvinduc
cn
inflamm
abl
confirm
neutrophil
involv
bbb
disrupt
jhmv
infect
previou
studi
show
jhmv
infect
mice
associ
increas
mortal
absenc
cell
infiltr
primari
effector
viral
clearanc
infect
cn
resid
cell
ligand
also
implic
chemoattract
cell
inflam
cn
howev
preliminari
result
show
migrat
cell
cn
mice
similar
control
mice
suggest
implic
cn
cell
recruit
jhmv
infect
contrast
signific
reduct
macrophag
infiltr
observ
indic
import
contribut
macrophag
migrat
within
cn
follow
jhmv
infect
observ
confirm
relev
use
mice
studi
implic
macrophag
releas
bbb
disrupt
express
peripher
monocyt
neutrophil
cn
present
oligodendrocyt
progenitor
cell
opc
brain
spinal
cord
one
studi
ligand
express
spinal
astrocyt
act
potent
promot
opc
prolifer
mediat
monocyt
arrest
flow
condit
cn
govern
migratori
arrest
oligodendrocyt
precursor
prolif
respons
develop
therefor
addit
properti
chemokin
migrat
describ
origin
interact
control
posit
opc
develop
spinal
cord
arrest
migrat
global
lack
associ
rel
resist
demyelin
interest
defin
function
myelin
repair
research
use
mice
initi
gener
balbc
background
studi
myelopoiesi
cross
mice
eight
gener
swxj
background
determin
role
demyelinationremyelin
process
vivo
use
mous
model
eae
cuprizon
intox
focal
demyelin
lysolecithin
lpc
inject
l
liu
abdelmadjid
belkadi
taofung
hu
k
choi
lindsey
darnal
robert
h
miller
r
ransohoff
unpublish
data
found
mice
rel
resist
induct
eae
diseas
onset
kinet
mortal
peak
day
diseas
sever
rare
mice
develop
sign
eae
equival
seen
litterm
interestingli
recoveri
initi
attack
eae
faster
robust
mice
diseas
score
resolut
phase
significantli
lower
mice
six
week
cuprizon
feed
signific
differ
tissu
area
affect
demyelin
observ
wildtyp
mice
demyelin
tissu
versu
mice
demyelin
tissu
similar
observ
obtain
day
lesion
induct
lpc
inject
wildtyp
mice
exhibit
demyelin
area
compar
mice
propos
hypothesi
mediat
pathogen
effect
eae
two
separ
level
first
act
arrest
receptor
myeloid
cell
promot
accumul
inflammatori
effector
cn
report
atherosclerosi
model
second
ligand
express
reactiv
astrocyt
lesion
edg
may
arrest
opc
block
remyelin
process
preclud
opc
entri
lesion
therebi
suppress
lesion
repair
propos
eae
lesion
might
resolv
effici
mice
lack
opc
address
issu
construct
radiat
bone
marrow
chimera
follow
subleth
irradi
bone
marrow
heterozyg
mice
use
reconstitut
give
rise
chimer
mice
chimer
mice
express
hematopoiet
cell
mice
select
lack
opc
radioresist
cell
found
strong
evid
absenc
cn
associ
improv
lesion
repair
eae
mice
compar
incid
eae
indic
loss
function
leukocyt
caus
reduc
incid
eae
mice
day
onset
peak
diseas
reflect
kinet
neurolog
impair
sever
eae
equival
group
mice
howev
seen
previous
mice
time
extent
recoveri
acceler
mice
lack
cn
result
suggest
absenc
cn
led
improv
repair
eae
lesion
notion
support
observ
lesion
size
mice
compar
peak
eae
correl
equival
diseas
score
stage
howev
recoveri
phase
day
onset
neurolog
sign
found
significantli
smaller
lesion
mice
furthermor
cuprizon
intox
found
equal
demyelin
mice
week
cuprizon
treatment
howev
mice
exhibit
enhanc
remyelin
day
remov
cuprizon
compar
mice
similar
result
found
lpc
inject
l
liu
belkadi
hu
k
choi
l
darnal
r
h
miller
r
ransohoff
unpublish
data
therefor
block
might
confer
neuroprotect
antiinflammatori
effect
signal
pathway
bind
repres
chemokin
receptor
pair
play
multipl
function
development
patholog
process
first
known
receptor
previou
studi
demonstr
abnorm
migrat
cerebellar
neuron
mice
suggest
role
axi
cn
develop
bind
caus
activ
seri
downstream
signal
pathway
regul
cell
prolifer
migrat
surviv
cn
recent
orphan
receptor
previous
term
shown
second
receptor
accord
gene
structur
chromosom
locat
high
affin
new
chemokin
receptor
term
interestingli
anoth
cxc
chemokin
formerli
known
ifninduc
cell
chemoattract
also
bind
high
affin
effort
concentr
understand
role
cn
relationship
variou
cxc
ligand
identifi
far
although
express
variou
cell
type
peripher
tissu
well
cn
role
peripher
tissu
poorli
understood
bind
provid
cultur
receptorbear
cell
growth
surviv
advantag
increas
adhes
properti
howev
signal
pathway
trigger
bind
remain
controversi
number
mutual
contradictori
publish
result
cancer
biolog
may
envis
interest
target
express
mrna
level
increas
malign
glioma
compar
normal
brain
tissu
situ
hybrid
confirm
express
confin
vessel
glioma
normal
cn
tissu
furthermor
demonstr
also
express
tumorassoci
vasculatur
breast
lung
tumor
enhanc
express
tumor
cell
promot
tumor
growth
also
enhanc
progress
metastas
plausibl
work
sequest
make
potenti
target
intervent
tumor
biolog
relev
specif
small
molecular
compound
inhibit
growth
human
tumor
cell
mous
tumor
model
therefor
blockad
approach
inhibit
effect
metastat
spread
major
area
research
consist
previou
observ
mrna
express
studi
demonstr
express
earli
develop
cn
howev
observ
signific
differ
distribut
major
cn
cell
popul
wildtyp
mice
hippocampu
dentat
gyru
cerebellum
mice
appear
normal
develop
spinal
cord
dorsal
root
ganglia
embryon
day
normal
neurogenesi
occur
express
maintain
neural
tube
observ
indic
directli
involv
neurogenesi
import
note
mani
development
defect
associ
defici
defect
includ
among
other
distort
laminar
structur
abnorm
migrat
cell
prolif
extern
granul
layer
develop
cerebellum
establish
prolifer
aggreg
absenc
foliat
zebrafish
import
role
reveal
recent
develop
later
line
mechanosensori
system
compris
sensori
organ
neuromast
neuromast
origin
migrat
primordium
move
head
tail
develop
later
line
express
posteriorlater
line
complementari
express
pattern
describ
particular
express
strong
posterior
part
absent
lead
half
primordium
express
mainli
detect
lead
part
primordium
morpholino
knockdown
lead
defici
migrat
primordium
eventu
affect
distribut
neuromast
studi
also
support
observ
show
antisens
knockdown
specif
affect
migrat
trail
cell
result
tissu
stretch
studi
need
delin
detail
downstream
mechan
mammalian
develop
understand
mechan
govern
express
regul
chemokin
receptor
crucial
defin
consequ
chemokin
receptor
blockad
therapeut
purpos
chemokin
receptordefici
murin
model
instrument
defin
role
chemokin
vivo
inflammatori
condit
result
implic
signal
chemokin
receptor
consumpt
clearanc
specif
ligand
receptor
promiscu
ligand
bind
alter
express
altern
ligand
present
high
level
observ
increas
ligand
level
chemokin
receptordefici
mice
carri
relev
therapeut
applic
chemokin
biolog
particular
chemokin
elev
may
repres
valuabl
biomark
efficaci
block
molecul
importantli
phenomenon
need
taken
account
unexpect
although
necessarili
detriment
consequ
might
aris
studi
show
global
defici
associ
rel
resist
demyelin
howev
use
three
differ
vivo
model
found
reconstitut
hematopoiet
cell
rescu
demyelin
blockad
might
promot
remyelin
ms
lesion
well
reduc
inflamm
therefor
block
might
confer
neuroprotect
antiinflammatori
effect
among
therapeut
strategi
investig
treatment
ms
sever
group
focu
prevent
leukocyt
infiltr
within
cn
implic
bbb
disrupt
constitut
potenti
promis
target
ms
treatment
fig
moreov
treatment
eae
mmp
inhibitor
show
interest
find
inhibitor
abandon
sideeffect
result
lack
inhibitor
select
inde
mmp
also
display
benefici
role
particularli
tissu
repair
regard
data
import
know
exact
role
sourc
mmp
ms
pathogenesi
use
mmp
inhibitor
treatment
data
demonstr
direct
effect
bbb
disrupt
identifi
cell
type
implic
releas
would
bring
addit
inform
essenti
potenti
ms
therapeut
strategi
also
target
inhibit
clinic
intervent
particularli
cancer
biolog
effort
concentr
defin
specif
action
chemokin
receptor
brain
linkag
peripher
element
neuroinflammatori
condit
hope
success
clinic
therapeut
approach
might
develop
